Skip to Content
Merck
CN

Structural basis for GPR40 allosteric agonism and incretin stimulation.

Nature communications (2018-04-27)
Joseph D Ho, Betty Chau, Logan Rodgers, Frances Lu, Kelly L Wilbur, Keith A Otto, Yanyun Chen, Min Song, Jonathan P Riley, Hsiu-Chiung Yang, Nichole A Reynolds, Steven D Kahl, Anjana Patel Lewis, Christopher Groshong, Russell E Madsen, Kris Conners, Jayana P Lineswala, Tarun Gheyi, Melbert-Brian Decipulo Saflor, Matthew R Lee, Jordi Benach, Kenton A Baker, Chahrzad Montrose-Rafizadeh, Michael J Genin, Anne R Miller, Chafiq Hamdouchi
ABSTRACT

Activation of free fatty acid receptor 1 (GPR40) by synthetic partial and full agonists occur via distinct allosteric sites. A crystal structure of GPR40-TAK-875 complex revealed the allosteric site for the partial agonist. Here we report the 2.76-Å crystal structure of human GPR40 in complex with a synthetic full agonist, compound 1, bound to the second allosteric site. Unlike TAK-875, which acts as a Gαq-coupled partial agonist, compound 1 is a dual Gαq and Gαs-coupled full agonist. compound 1 binds in the lipid-rich region of the receptor near intracellular loop 2 (ICL2), in which the stabilization of ICL2 by the ligand is likely the primary mechanism for the enhanced G protein activities. The endogenous free fatty acid (FFA), γ-linolenic acid, can be computationally modeled in this site. Both γ-linolenic acid and compound 1 exhibit positive cooperativity with TAK-875, suggesting that this site could also serve as a FFA binding site.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
2,2-Dimethyl-1,3-propanediol, 99%
Sigma-Aldrich
Cholesteryl hemisuccinate tris salt, anionic detergent
Sigma-Aldrich
Maltose solution, BioReagent, ~20% in H2O, Molecular Biology